Avoidance of Hyperglycaemia in People With Type 1 Diabetes

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

253 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-02

Study Completion Date

2022-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to learn more about avoidance of hyperglycaemia in adults with type 1 diabetes. People who attend a type 1 diabetes clinic will be invited to complete a number of self-report questionnaires and a survey. A subsection of people who experience avoidance of hyperglycaemia will be invited to take part in an interview in order to gain a more in-depth understanding of this issue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HIT on Hypoglycaemic Risk in T1D

NCT05044442

Type1diabetes

COMPLETED NA

Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children

NCT00487006

Critical Illness Hyperglycemia

COMPLETED NA

Naltrexone and Hypoglycemia in Type 1 Diabetes

NCT01053078

Type 1 Diabetes Hypoglycemia Unawareness

COMPLETED PHASE1/PHASE2

Achieving Normal Glucose In Hospital Settings

NCT01359241

Dysglycaemia

COMPLETED NA

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

NCT01462227

Hypoglycemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Questionnaire group

Individuals who attend the type 1 diabetes clinic will complete a number of self-report questionnaires and a survey.

No intervention

Intervention Type OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 1 diabetes of at least 6 months duration

Exclusion Criteria

* Inability to understand or write in the English language
* Pregnant women
* Unable to participate in the study due to other factors, as assessed by the Chief Investigators

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No